| 000 | 01541 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250516104008.0 | ||
| 264 | 0 | _c20121022 | |
| 008 | 201210s 0 0 eng d | ||
| 022 | _a1460-2105 | ||
| 024 | 7 |
_a10.1093/jnci/djs312 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPharoah, Paul D P | |
| 245 | 0 | 0 |
_aRe: CYP2D6 genotype and tamoxifen response in postmenopausal women with endocrine-responsive breast cancer: the Breast International Group 1-98 trial and Re: CYP2D6 and UGT2B7 genotype and risk of recurrence in tamoxifen-treated breast cancer patients. _h[electronic resource] |
| 260 |
_bJournal of the National Cancer Institute _cAug 2012 |
||
| 300 |
_a1263-4; author reply 1266-8 p. _bdigital |
||
| 500 | _aPublication Type: Letter; Comment | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents, Hormonal _xtherapeutic use |
| 650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aCytochrome P-450 CYP2D6 _xgenetics |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGlucuronosyltransferase _xgenetics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aNeoplasm Recurrence, Local _xepidemiology |
| 650 | 0 | 4 |
_aNitriles _xtherapeutic use |
| 650 | 0 | 4 | _aPolymorphism, Single Nucleotide |
| 650 | 0 | 4 | _aPostmenopause |
| 650 | 0 | 4 |
_aTamoxifen _xtherapeutic use |
| 650 | 0 | 4 |
_aTriazoles _xtherapeutic use |
| 700 | 1 | _aAbraham, Jean | |
| 700 | 1 | _aCaldas, Carlos | |
| 773 | 0 |
_tJournal of the National Cancer Institute _gvol. 104 _gno. 16 _gp. 1263-4; author reply 1266-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/jnci/djs312 _zAvailable from publisher's website |
| 999 |
_c21990543 _d21990543 |
||